Latest Novartis Stories

BASEL, Switzerland, Sept. 21, 2012 /PRNewswire/ -- Syngenta, in conjunction with the Governor of Krasnodarskiy Krai, Russia, has signed a Letter of Intent to invest up to $85 million in the construction of a hybrid seed and crop protection production facility. John Atkin, Chief Operating Officer, said: "Technology will play a key role in realizing Russia's ambition to intensify its agriculture sustainably. This also represents a significant economic opportunity for Russian...

PITTSBURGH, Sept. 21, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Valsartan and Hydrochlorothiazide Tablets USP, 80/12.5 mg, 160/12.5 mg, 160/25 mg, 320/12.5 mg and 320/25 mg. This product is the generic version of Novartis' Diovan HCT(®) Tablets, which are indicated for the treatment of...

BASEL, Switzerland, Sept. 21, 2012 /PRNewswire/ -- Communication in accordance with article 8 of the Belgian Royal Decree of 27 April 2007 on public takeover bids. Syngenta announced today the intention to launch, via its subsidiary Syngenta Crop Protection AG, a voluntary and conditional public takeover bid in cash for all shares and warrants issued by Devgen NV. The bid offers a price of euro 16 per share and the price for warrants has been determined in conformity with market...

SAINT GENIS POUILLY, France, September 19, 2012 /PRNewswire/ -- Highlights - Lutathera(R) is the first theragnostic drug in Molecular Nuclear Medicine (MNM) to enter phase III clinical development - First European patient enrolled on July 20,2012; first US patient expected to be enrolled in Q4 2012 - Phase II results in progressive midgut carcinoid showed Progression-Free Survival of more than 44 months...

OKLAHOMA CITY, Sept. 19, 2012 /PRNewswire/ -- Selexys Pharmaceuticals, Corp., announced today that it has successfully completed a $23 million Series A equity financing, led by MPM Capital. Additionally, Selexys entered into an agreement with Novartis Pharmaceuticals whereby Novartis has been granted an exclusive option to acquire Selexys and its lead asset, the anti-P-selectin antibody SelG1, following the successful completion of a Phase 2 clinical study in patients with sickle...

WATERTOWN, Mass., Sept. 19, 2012 /PRNewswire/ -- Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, announced today that Enanta was named by FierceBiotech as one of 2012's Fierce 15. The annual award, which was announced today during the BioPharm America Conference at the Westin Boston Waterfront Hotel in Boston, was created by FierceBiotech to recognize 15 promising...

BASEL, Switzerland, Sept. 19, 2012 /PRNewswire/ -- Unique biological technology for nematode control Revolutionary production process First seed treatment for soybean cyst nematode: US launch in 2014 Supports integrated offer across key crops Syngenta announced today that it has agreed to acquire Pasteuria Bioscience, Inc., a US-based biotechnology company. Since 2011 Syngenta and Pasteuria have had an exclusive global technology partnership to develop and commercialize...

In a special report in The Lancet, researchers from Queen Mary, University of London (UK) argue that pending cases against India's patent laws threaten public health and misinterpret international intellectual property agreements. The report, which is published today (Monday), highlights legal challenges by two pharmaceutical companies, Bayer and Novartis, to key provisions of India's Patents Act. Bayer's appeal was heard last week, and the Indian Supreme Court is due to hear Novartis'...

BASEL, Switzerland, Sept. 7, 2012 /PRNewswire/ -- Syngenta announced today that Caroline Luscombe, Head of Human Resources, will join the Executive Committee with effect from October 1, 2012. Ms Luscombe joined Syngenta in January 2010 and has successfully led the Human Resources function through implementation of the new integrated strategy. Her previous HR experience includes senior roles at General Electric and in the chemical and pharmaceutical industries. Syngenta is one of...

BASEL, Switzerland, Sept. 6, 2012 /PRNewswire/ -- The Syngenta Photography Award, a new international competition that aims to stimulate dialogue around key global challenges, was launched today. Open to professional and amateur photographers, the Award will explore a central theme each year. In its inaugural year, the theme is "rural-urban", exploring the relationship and tensions between rural and urban environments. "For the first time in history, over half of the world's...